scholarly journals P276 Risk matrix model for prediction of one-year surgery in Crohn’s disease

2018 ◽  
Vol 12 (supplement_1) ◽  
pp. S240-S241
Author(s):  
N Imperatore ◽  
A Rispo ◽  
A Testa ◽  
L Bucci ◽  
G Luglio ◽  
...  
2018 ◽  
Vol 50 (2) ◽  
pp. e73-e74
Author(s):  
N. Imperatore ◽  
A. Rispo ◽  
A. Testa ◽  
L. Bucci ◽  
G. Luglio ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-5
Author(s):  
Mirzafaraz Saeed ◽  
Hari Hullur ◽  
Amro Salem ◽  
Abbas Ali ◽  
Yousif Sahib ◽  
...  

Introduction. The aim of this study is to evaluate the outcome of introduction of early surgery in the course of isolated ileocecal Crohn’s disease, where there is no absolute indication of surgery. Methods. Observational study involving patients with isolated ileocecal Crohn’s disease who underwent early surgical resection (within one year of the presentation of the hospital). A complete blood count, ESR, and CRP were done and compared between the preoperative value, 1st postoperative visit (3-4 weeks), and last follow-up visit. Statistical analysis was done using Analysis of Variance (ANOVA) to compare the different figures. Results. There was a statistically significant increase in the hemoglobin levels between preoperative, postoperative, and long-term follow-up and a significant decrease in leukocyte count between the pre- and postoperative values (F=19.8, p<0.001 and F=8.9, p=0.002, resp.). Similarly, the ESR and CRP values were decreased significantly at long-term follow-up (F=8.5, p=0.019 and F=8.3, p=0.013, resp.). Conclusion. Early surgical resection in isolated ileocaecal Crohn’s disease achieved significant biochemical improvements. These successful results in this small number of patients indicate that early surgical intervention may provide better outcomes. These initial results encourage larger and comparative studies of long-term results versus long-term use of biological agents.


2016 ◽  
Vol 48 ◽  
pp. e157-e158
Author(s):  
M. Serio ◽  
K. Efthymakis ◽  
A. Milano ◽  
A. Pierro ◽  
F. Laterza ◽  
...  

2014 ◽  
Vol 8 (8) ◽  
pp. 789-795 ◽  
Author(s):  
Anders Lasson ◽  
Hans Strid ◽  
Lena Öhman ◽  
Stefan Isaksson ◽  
Mikael Olsson ◽  
...  

2015 ◽  
Vol 148 (4) ◽  
pp. S-457
Author(s):  
Peter L. Lakatos ◽  
Nora Sipeki ◽  
Gary L. Norman ◽  
Zakera Shums ◽  
Peter Antal-Szalmas ◽  
...  

2013 ◽  
Vol 144 (5) ◽  
pp. S-173 ◽  
Author(s):  
Miguel Regueiro ◽  
Leonard Baidoo ◽  
Kevin E. Kip ◽  
Jason M. Swoger ◽  
David G. Binion ◽  
...  

1998 ◽  
Vol 12 (4) ◽  
pp. 270-272 ◽  
Author(s):  
Kelly W Burak ◽  
Ronald J Bridges ◽  
Walter B Blahey

A rare case of Castleman's disease presenting as Crohn's disease is described. This 21-year-old male with chronic neutropenia for one year presented with recurrent right lower quadrant pain of two years' duration. Small bowel follow-through suggested Crohn's of the terminal ileum. Colonoscopy confirmed ulcerations in the terminal ileum and cecum, with biopsies showing necrosis and inflammation. Treatment was initiated with prednisone, 5-aminosalicylate and granulocyte colony-stimulating factor for neutropenia. Symptoms recurred one year later, and repeat colonoscopy showed a focal cecal ulceration. Two years after presentation a resection was planned. Laparotomy revealed a normal ileocecal region and a large retroperitoneal mass of lymphadenopathy. Biopsies confirmed reactive hyperplasia, consistent with the plasma cell variant of Castleman's disease. Chemotherapy has resulted in improvement of symptoms and decrease in mass size, but cecal ulceration persisted. This case illustrates a variant presentation of Castleman's disease with neutropenia and manifestations in the gastrointestinal tract.


2008 ◽  
Vol 134 (4) ◽  
pp. A-665-A-666
Author(s):  
Jason E. Gonzaga ◽  
Mazen Issa ◽  
Susan Skaros ◽  
Joshua F. Knox ◽  
Jeanne Emmons ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document